Pharma major Merck has signed non-exclusive voluntary licensing agreements with four Indian drugmakers: Aurobindo Pharma, Cipla, Emcure, and Viatris. These agreements will enable the supply of its investigational, once-monthly oral HIV pill, Alimatravir, in 129 low- and middle-income countries (LMICs). The royalty-free agreements aim to expand access to the drug in regions that account for a substantial majority of new HIV diagnoses globally. This initiative is expected to significantly improve the availability and affordability of the treatment in these high-need areas.
- Merck signed non-exclusive voluntary licensing agreements with four Indian drugmakers for its HIV pill, Alimatravir.
- The Indian drugmakers involved are Aurobindo Pharma, Cipla, Emcure, and Viatris.
- The agreements are royalty-free and aim to supply the once-monthly oral HIV pill in 129 low- and middle-income countries.
India has approved Qdenga, its first dengue vaccine, designed to protect against all four serotypes of the virus. However, clinical trial data from manufacturer Takeda raises a crucial safety concern, particularly for seronegative children (those not previously infected). The vaccine could potentially enhance dengue in these children, specifically against DENV-3, and its efficacy against DENV-4 remains unknown. Experts recommend screening for prior dengue exposure before vaccination for seronegative recipients to mitigate the risk of Antibody-Dependent Enhancement (ADE).
- India has approved Qdenga, its first dengue vaccine, targeting all four serotypes.
- A significant safety caveat exists for seronegative children, who may experience enhanced dengue (ADE).
- Qdenga's efficacy against DENV-3 is problematic for seronegative individuals, and DENV-4 efficacy is unknown.
A three-year study, published in Gut Microbes, indicates that urban food habits are rewriting the gut microbiome in India, potentially explaining the rising rates of diabetes, obesity, and hypertension among urbanising Indians. The study, led by Niraj Rai and Maanasa Raghavan, profiled gut bacteria from 575 adults across 10 communities in India and Sri Lanka. It found that urban individuals consistently have more Megamonas, a bacterium linked to obesity and high blood glucose, while Holdemanella, associated with fibre intake, is lost with urbanisation. India, with 89.8 million adults living with diabetes as of 2024, faces a significant health challenge, with 43% of cases undiagnosed. The research highlights food processing as a key driver of these microbiome changes.
- A study in Gut Microbes suggests urban food habits are altering the gut microbiome in India, contributing to rising diabetes, obesity, and hypertension.
- The research found higher levels of Megamonas, linked to obesity and high blood glucose, in urban populations.
- Holdemanella, associated with fibre intake, was found to be lost with urbanisation, except in Kerala where traditional diets are maintained.
Rajasthan's health department has heightened surveillance and vector-control measures in Dungarpur, Sirohi, and surrounding areas after two girls from the state, undergoing treatment in Gujarat, tested positive for the Chandipura virus (CHPV) and died. CHPV is an emerging vector-borne pathogen primarily affecting children under 15, causing fever, flu-like symptoms, and acute encephalitis. It is transmitted by vectors such as mosquitoes, ticks, and sandflies. The intensified measures aim to prevent further spread of the virus in the affected districts.
- Rajasthan's health department has increased surveillance and vector-control measures in Dungarpur, Sirohi, and adjoining areas.
- The alert follows the deaths of two girls from the state who tested positive for the Chandipura virus (CHPV).
- CHPV is an emerging vector-borne pathogen that mainly affects children under 15, causing symptoms like fever and encephalitis.
The CDSCO's approval of Qdenga, India's first dengue vaccine, is a significant step, following its licensing in over 40 countries and WHO prequalification. However, the editorial cautions against complacency. Concerns include the vaccine's varying protection against different serotypes (especially DENV-3 and DENV-4), the two-dose regimen's logistical challenges for mobile populations, and potential 'negative efficacy' issues in seronegative children from the TIDES trial. The article stresses the need for government negotiation for lower pricing to ensure affordability and uptake among high-risk populations, particularly in dense urban slums where conventional vector control is difficult.
- India has approved Qdenga, its first dengue vaccine, following international licensing and WHO prequalification.
- The vaccine's efficacy varies across the four dengue serotypes, with concerns about protection against DENV-3 and DENV-4.
- Logistical challenges exist for administering the two-dose regimen, especially for highly mobile populations.
A HelpAge India study highlights that senior citizens are particularly vulnerable to climate change, experiencing both sudden shocks and slow-onset stresses. Factors like financial capacity, living alone, gender, age, poor health, and insecure housing exacerbate their risk. The study emphasizes an "Intersectional Place Perspective" to understand how these factors interact, making uneducated, poor, widowed elderly women most vulnerable. Recommendations include layered responses at household and community levels, such as storing food/water, improving shelter, and community support networks. Policy suggestions include climate-resilient healthcare, expanded social protection, better disaster preparedness, and targeted support for high-risk groups, advocating a shift from 'hazard-centred' to 'people-centred' systems.
- Senior citizens are highly vulnerable to climate change impacts, including both sudden shocks and slow-onset stresses.
- Vulnerability is exacerbated by factors like financial dependence, living alone, poor health, and insecure housing.
- The study advocates for a "people-centred" approach, shifting from 'hazard-centred' to 'people-centred' systems to address the specific needs of the elderly.
Delhi's new winter pollution management framework, with measures like staggered office timings and construction restrictions, marks a shift towards advance planning. However, the authors argue that AI-powered forecasts are crucial to optimize public health decisions, especially regarding outdoor activities. Historical data shows PM2.5 concentrations are significantly lower in the late afternoon (3-6 pm) compared to morning (9 am-12 pm). AI models, combining weather forecasts, satellite observations, and emissions data, can provide hour-by-hour predictions, transforming air quality bulletins into practical decision-support tools for schools, events, and outdoor workers, thereby reducing exposure effectively.
- Delhi's new winter pollution framework aims for advance planning, but needs AI forecasts for effective implementation.
- PM2.5 concentrations are significantly lower in Delhi during late afternoons compared to mornings.
- AI models can provide hour-by-hour pollution predictions by integrating various data sources.
A recent study involving over 12,000 Indians has found a significant link between long-term exposure to air pollution and kidney damage. The study, published in the journal Kidney International, indicates that even moderate levels of particulate matter (PM2.5) can lead to a decline in kidney function over time. This silent damage poses a serious public health threat, especially in India where air pollution levels are high. The findings underscore the urgent need for stricter air quality regulations and public health interventions to mitigate the adverse effects of pollution on kidney health and overall well-being.
- A study of over 12,000 Indians links long-term air pollution exposure to kidney damage.
- Even moderate levels of PM2.5 can lead to a decline in kidney function over time.
- This silent damage from air pollution poses a significant public health threat in India.
Premenstrual Mood Symptom (PMOS), a severe form of PMS, now affects one in five women, with its prevalence on the rise. PMOS involves debilitating physical and psychological symptoms that significantly impact daily life. The increase is attributed to various factors including lifestyle changes, increased stress, dietary habits, and hormonal imbalances. The article emphasizes the need for greater awareness, early diagnosis, and comprehensive management strategies, including lifestyle modifications, dietary changes, and medical interventions. Understanding the underlying causes and providing adequate support are crucial to help women manage PMOS and improve their quality of life.
- Premenstrual Mood Symptom (PMOS), a severe form of PMS, affects one in five women and is increasing.
- PMOS involves debilitating physical and psychological symptoms that severely impact daily life.
- Lifestyle changes, increased stress, dietary habits, and hormonal imbalances are contributing factors to its rise.
Recent research suggests that Omega-3 fatty acid supplements may not consistently provide significant heart health benefits for everyone, particularly those without pre-existing cardiovascular disease. While Omega-3s are known for their anti-inflammatory properties and can lower triglycerides, studies indicate that for healthy individuals, dietary sources like fatty fish might be more effective than supplements. The article highlights the importance of personalized nutrition and consulting healthcare professionals before relying solely on supplements. It emphasizes a holistic approach to heart health, including a balanced diet, regular exercise, and lifestyle modifications, rather than expecting a 'magic pill' solution from supplements.
- Recent research questions the consistent heart health benefits of Omega-3 supplements for all individuals.
- Dietary sources of Omega-3s, such as fatty fish, may be more effective than supplements for healthy individuals.
- Omega-3s are known to lower triglycerides and have anti-inflammatory properties.
Cancer care in India is becoming increasingly unaffordable, pushing many patients into financial distress. Despite advancements in treatment, high costs of diagnosis, drugs, and therapies make it inaccessible for a large segment of the population. The article highlights the need for comprehensive health insurance, government support, and price regulation for cancer treatments. It also emphasizes the importance of early detection and preventive measures to reduce the overall burden. Ensuring equitable access to quality cancer care requires a multi-pronged approach involving policymakers, healthcare providers, and pharmaceutical companies to make treatments affordable and available to all.
- Cancer care in India is increasingly unaffordable, leading to financial hardship for many patients.
- High costs of diagnosis, drugs, and therapies make quality treatment inaccessible to a large population.
- Comprehensive health insurance, government subsidies, and price regulation are crucial for making cancer care affordable.
Cuban Ambassador to India, Juan Carlos Marsan Aguilera, called for the lifting of the energy blockade imposed by the United States, stating it has caused a "collective punishment" and a humanitarian crisis in Cuba. The blockade has severely impacted all sectors of the Cuban economy, including electricity supply, healthcare, water supply, food production, and transportation. Aguilera highlighted "unprecedented suffering," citing over 100,000 pending medical surgeries, increased infant mortality, and a decline in cancer survival rates. He argued that no country has the right to impose unilateral energy blockades, especially in the context of renewed hostilities with Iran and the Strait of Hormuz.
- The Cuban Ambassador to India urged the U.S. to lift the energy blockade on Cuba, calling it a "collective punishment."
- The blockade has led to a humanitarian crisis, severely affecting Cuba's economy and essential services like healthcare and food.
- Significant impacts include over 100,000 pending medical surgeries and increased infant mortality rates.
Non-animal testing models (NAMs) are becoming crucial for the next phase of pharmaceutical growth, especially for India's transition from generic manufacturing to original drug discovery. Currently, only 10-14% of drug candidates entering clinical trials receive regulatory approval, partly due to animal testing's poor predictive accuracy for human body behavior. NAMs, including organoids, organ-on-chip platforms, and AI-enabled computational models, offer human biology-grounded insights, improving predictive accuracy and shortening development timelines. India needs a national framework and clear regulations to integrate NAMs effectively, leveraging its strengths in generics and biosimilars to become a hub for drug discovery and innovation.
- Non-animal testing models (NAMs) are essential for improving drug discovery and reducing reliance on animal testing.
- Animal testing often has poor predictive accuracy, contributing to high failure rates in drug development.
- NAMs like organoids and AI-enabled models offer more human-relevant insights, improving accuracy and speeding up timelines.
The National Medical Commission (NMC) will no longer process "routine" requests from faculty members and medical colleges for determining eligibility for teaching positions. The Post Graduate Medical Education Board (PGMEB) stated that the responsibility for assessing eligibility now primarily rests with the appointing authority, such as the medical institution or university, using the provisions of the Medical Institutions (Qualifications of Faculty) Regulations, 2025. More complicated cases will still be referred to the NMC but must be submitted through an institution, accompanied by a fee of ₹25,000. This shift aims to streamline the process and empower institutions.
- The NMC will cease processing routine faculty eligibility requests for medical teaching positions.
- The primary responsibility for determining faculty eligibility now lies with the appointing medical institutions or universities.
- This change is based on the Medical Institutions (Qualifications of Faculty) Regulations, 2025.
Novo Nordisk's weight loss drug Wegovy (semaglutide injection 2.4 mg) has received approval from the Central Drugs Standard Control Organization (CDSCO) in India for a new indication: the treatment of non-cirrhotic metabolic dysfunction associated steatohepatitis (MASH) in adults with moderate to advanced liver fibrosis. This makes Wegovy the first and only GLP-1 RA approved globally and in India for MASH, a liver disease caused by excess fat buildup, chronic inflammation, and liver damage. The approval, alongside a reduced calorie diet and increased physical activity, marks a significant milestone in treating this condition.
- Novo Nordisk's drug Wegovy has been approved in India for treating fatty liver disease.
- The approval is for non-cirrhotic metabolic dysfunction associated steatohepatitis (MASH) in adults.
- Wegovy is the first and only GLP-1 RA approved globally and in India for MASH.
The Supreme Court has sought responses from the Centre and States on a petition advocating for the recognition of intersex persons as a distinct and identifiable class. The petition, filed by advocate Shamshravish Rein, seeks a directive for the Union government to establish separate statutory guidelines within six months. These guidelines would provide distinct recognition, protection, and affirmative support for individuals born with congenital variations in sex characteristics (DSD). The plea highlights the traumatic challenges faced by intersex children, including forced medical interventions, social abandonment, and exclusion from various societal structures due to a strictly binary understanding of sex.
- The Supreme Court is considering a petition for distinct recognition of intersex persons.
- The petition seeks statutory guidelines for protection and affirmative support for individuals with Differences of Sex Development (DSD).
- Intersex individuals face unique challenges, including forced medical interventions and social exclusion.
The U.S. is experiencing a widespread cyclosporiasis outbreak, a gastrointestinal illness caused by the microscopic parasite Cyclospora cayetanensis. Over 1,645 confirmed domestic cases have been reported since May 1, with thousands more under analysis, significantly exceeding previous years. The infection spreads through contaminated food or water, not person-to-person, causing symptoms like watery diarrhoea, bloating, and fatigue, which can last for weeks and be severe in vulnerable groups. Diagnosis is challenging, requiring multiple stool samples. Treatment involves trimethoprim-sulfamethoxazole, and prevention focuses on thorough washing of fresh produce and safe food handling practices.
- A widespread cyclosporiasis outbreak is affecting the U.S., with over 1,645 confirmed cases since May 1.
- The illness is caused by the Cyclospora cayetanensis parasite, transmitted through contaminated food or water.
- Symptoms include severe watery diarrhoea, bloating, and fatigue, lasting from days to over a month.
GLP-1 based medicines, widely used for obesity and type 2 diabetes, are showing dermatological consequences beyond their primary role in weight loss. Rapid weight reduction can lead to visible changes such as facial volume loss ('Ozempic face'), loose skin, hair shedding (telogen effluvium), and nail changes, often reflecting nutritional stress. The article emphasizes the need for coordinated care between endocrinologists and dermatologists to manage these effects, which can impact comfort and confidence. Furthermore, GLP-1s show early anti-inflammatory promise for skin diseases like psoriasis and hidradenitis suppurativa, especially when coexisting with metabolic dysfunction, though more studies are needed.
- GLP-1 based medicines, used for obesity and type 2 diabetes, have visible dermatological consequences.
- Rapid weight loss can lead to facial volume loss, loose skin, hair shedding, and nail changes.
- These changes may indicate nutritional deficiencies or underlying conditions, requiring proper assessment.
Alexander Zverev's recent French Open victory, making him the first Type 1 diabetes (T1D) patient to win a Grand Slam, has brought significant attention to managing this chronic condition in elite sports. Diagnosed at age four, Zverev relies on insulin therapy and continuous glucose monitoring (CGM) to manage fluctuating blood sugar levels, a process he describes as 'playing two games at once.' The article explains T1D, the risks of hyperglycaemia and hypoglycaemia, and the physical and mental burdens faced by athletes, including issues like 'Ozempic face,' hair shedding, and the need for careful nutritional and aesthetic planning. Zverev also advocates for TID awareness through his foundation.
- Alexander Zverev's French Open win marks a historic achievement for an athlete with Type 1 diabetes (T1D).
- Managing T1D in elite sports involves constant monitoring of blood glucose levels and insulin administration.
- Athletes face challenges like hyperglycaemia, hypoglycaemia, and physical/mental burnout due to the condition.
The Centre has released the draft National Health Research Policy 2026, aiming to align India's scientific research with its disease burden and public health priorities. The policy proposes a wide-ranging restructuring of the health research ecosystem, focusing on indigenous innovation and evidence-based policymaking. It seeks to address issues like fragmented research efforts, regional disparities, and slow translation of findings into healthcare. Key proposals include a system for identifying priority research areas, a three-tier governance structure, and core principles like ethics, data governance, and community participation.
- The draft National Health Research Policy 2026 aims to align research with India's disease burden and public health priorities.
- It proposes a comprehensive restructuring of India's health research ecosystem.
- The policy seeks to address existing problems such as fragmented research and regional disparities in research capacity.
Protein biosensors are revolutionizing medical diagnostics by enabling rapid detection of disease-relevant proteins, crucial for conditions like sepsis. Building on Leland C. Clark, Jr.'s 1962 work, modern biosensors pair biological recognition elements with transducers. Aptamers, synthetic DNA/RNA strands, have replaced antibodies due to their stability and cost-effectiveness. Nanotechnology, incorporating materials like gold nanoparticles and graphene, enhances sensitivity. The integration of CRISPR and multi-marker detection further improves diagnostic accuracy. Future developments include wearable monitoring and closed-loop therapeutic systems, though challenges in calibration and clinical validation remain.
- Protein biosensors offer rapid diagnosis for medical emergencies by detecting disease-relevant proteins in blood.
- Aptamers, synthetic DNA/RNA strands, are now preferred over antibodies as recognition elements due to their stability and cost-effectiveness.
- Nanotechnology, using materials like gold nanoparticles and graphene, significantly enhances biosensor sensitivity.
The Union Ministry of Agriculture has notified a ban on paraquat dichloride, a herbicide associated with thousands of deaths due to self-harm, homicides, and accidental deaths in India. This decision follows similar bans by various states, including Andhra Pradesh, Telangana, and Kerala. Farmers commonly use paraquat dichloride after harvest to clear land for the next crop. Doctors Against Paraquat campaigner, Marri Mahesh Reddy, welcomed the ban, highlighting the absence of an antidote for the chemical.
- The Union government has banned paraquat dichloride, a herbicide.
- The herbicide is linked to thousands of deaths from self-harm, homicides, and accidental causes.
- Several states, including Andhra Pradesh, Telangana, and Kerala, had already banned the chemical.
India's Civil Registration System (CRS) has seen significant improvement, with a substantial increase in birth and death registrations, especially in states like Uttar Pradesh, Bihar, and Madhya Pradesh. This progress is crucial for accurate demographic data, policy formulation, and service delivery. However, gaps remain, particularly in death registration and among specific social groups. The article highlights the benefits of a robust CRS, including better health planning, social security, and electoral rolls, while also pointing out challenges like incomplete coverage in some areas and the need for digital integration and public awareness campaigns to ensure universal and timely registration.
- India's Civil Registration System (CRS) has significantly improved, leading to higher birth and death registrations.
- Improved CRS data is vital for accurate demographic statistics, policy formulation, and service delivery.
- Gaps persist, particularly in death registration and among certain social groups and regions.
Gene drives, a technology designed to engineer evolution, offer potential solutions for global challenges like malaria and invasive species. However, their ability to spread genetic modifications rapidly through populations raises significant ethical and ecological concerns. The technology, which bypasses natural inheritance, could have unintended consequences, including the creation of resistant populations or ecosystem disruptions. Scientists advocate for a cautious, transparent, and inclusive approach to research and deployment, emphasizing the need for robust governance, international collaboration, and public discourse to navigate the balance between potential benefits and risks.
- Gene drives are a powerful technology that can rapidly spread genetic modifications through populations.
- They offer potential solutions for global problems like malaria, invasive species, and agricultural pests.
- Significant ethical and ecological concerns exist regarding unintended consequences and ecosystem disruption.